Povidone iodine

聚维酮碘

Report date: 2026/02/04 17:57:07

Base Information

Drug NamePovidone iodine
Drug Alias NameBetadineVBP-245
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionBacterial proteins modulatorsCell death stimulants
TargetsBacterial proteins
Therapy Area/IndicationsDisinfectantsCoronavirus Disease 2019 (COVID-19)Self Efficacy +[28] 
Global Approved IndicationsDisinfectantsVaginal DiseasesVirus Diseases +[7] 
Approved Indications in ChinaDisinfectantsVaginal DiseasesVirus Diseases +[7] 
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryCanadaUnited StatesThailand +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesIview Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCairo UniversityUniversity Of RochesterUniversity Of Wisconsin-Madison +[8] 
Inactive CompaniesThe Brigham and Women's HospitalChiang Mai UniversityYale University +[14] 
Active IndicationsDisinfectantsCoronavirus Disease 2019 (COVID-19)Self Efficacy +[16] 
Inactive IndicationsPostoperative ComplicationsKeratitisBlindness +[12] 

Other Information

ATC CodeD08AG02D09AA09D11AC06 +[6] 
Related LinksWikipediaDrugBankKEGG